HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Prudential PLC

Prudential PLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 33.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,956 shares of the company’s stock after selling 4,043 shares during the period. Prudential PLC’s holdings in HCA Healthcare were worth $2,388,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in HCA. Whipplewood Advisors LLC purchased a new stake in HCA Healthcare during the 4th quarter worth approximately $31,000. Tidemark LLC bought a new position in HCA Healthcare during the 4th quarter valued at $36,000. Legacy Investment Solutions LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter worth about $39,000. Activest Wealth Management lifted its position in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. raised its stake in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $332.53 on Monday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The firm has a market cap of $81.87 billion, a P/E ratio of 15.14, a PEG ratio of 1.10 and a beta of 1.48. The stock has a fifty day moving average price of $327.23 and a two-hundred day moving average price of $339.04. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the business posted $5.90 earnings per share. Research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were given a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.87%. HCA Healthcare’s dividend payout ratio (DPR) is 13.11%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on HCA shares. Truist Financial lowered their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Barclays reduced their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. Morgan Stanley cut their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.